Medical News
Addiction
Allergies
Alternative Medicine
Asthma
Cancer
Cardiology
Chiropractic
Dental
Dermatology
Diabetes
Emergency
Family Medicine
General
Geriatrics
Hospitals
Infectious Diseases
Internal Medicine
Managed Care / HMO
Medical Products
Mental Health
Neurology
Nursing
Nutrition
OB / GYN
Pediatrics
Pharmaceuticals
Physical Therapy
Plastic Surgery
Psychology
Radiology / Imaging
Research
Sports Medicine
Surgery
Vision

Stroke Rehabilitation System Biomove 3000 also Certified in Australia

Upper arm training
Upper arm training

Lifehealthcare, the largest distributor of medical equipment in Australia, will sell the Biomove in Australia.

Hashmonaim, Israel (PRWEB) June 8, 2007 --- Curatronic Ltd. announced today that the Australian Government has included the Biomove 3000 as medical device in the Australian Register of Therapeutic Goods.

Lifehealthcare's National Clinical Liaison Manager Jenni Dabelstein said, "It is a great opportunity for our company to be able to offer such an outstanding product to stroke victims in Australia. After extensive trials at several major centers in Brisbane we concluded that the Biomove is an excellent product and we are pleased to offer this device to the many stroke survivors in Australia. Our company makes consistently efforts to bring innovative products to patients, thereby helping to improve the overall standards of stroke treatment in Australia."

Lifehealthcare (www.lifehealthcare.com.au) is Australia's leading hospital and rehabilitation supply and distribution company and provides an extensive range of hospital and rehabilitation supplies and equipment across Australia. Recently the company included Lifestyle & Rehab www.lr.com.au in their Hospital & Rehab Division, consolidating their leading position in the Australian market.

The Biomove 3000 system was developed for rehabilitation therapy at home following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG signals that persist in spastic muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to these muscles, resulting in actual muscle movement by the patient.

Millions of people suffer from the debilitating effects of stroke. Fifty percent have some one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Ben Philipson, CEO of Curatronic Ltd. said, "We are very pleased that our economical, easy-to-use Biomove 3000 system will now also be available in this important market."

Biomove web site: www.biomove.com

Curatronic Ltd. was founded in 2000 as a privately held R&D company dedicated to developing affordable, easy to use state-of-the-art stroke rehabilitation and therapy devices for use by patients at home and by professional therapists.

Curatronic Ltd.
P.O.Box 1532
Hashmonaim
73127 Israel
Tel: + 972-8976-1441
Fax: + 972-8976-2020

Summary
After obtaining certification in Australia, Lifehealthcare now starts marketing of the highly affordable and easy to use Stroke Therapy device Biomove 3000 www.biomove.com , manufactured by Curatronic Ltd.

###

Simillar Articles

Stroke Rehabilitation System Biomove 5000 Approved by the US FDA
The US FDA approves marketing of the most advanced Stroke Rehabilitation system in the world, manufactured by the Israeli company Curatronic Ltd.
The American Occupational Therapy Association (AOTA) Endorses the NESS H200(R) Hand...
Bioness Inc. announced today that the NESS H200 Hand Rehabilitation System received the official endorsement of the American Occupational Therapy Association (AOTA).
Good Samaritan Hospital Encourages Stroke Awareness Through Free Education Sessions
To promote stroke awareness, Good Samaritan Hospital is providing free stroke education sessions to anyone interested in learning more about the risk factors and warning signs of a stroke.
Internationally Recognized Stroke Survivor Valerie Greene Offers the Wake-up Call Americans Need...
May is National Stroke Awareness Month and Valerie Greene, a two-time stroke survivor and a national spokesperson for the American Heart Association and American Stroke Association is speaking out...
M's Science Corporation Initiated European Phase 2 Study in Stroke Recovery
M's Science Corporation (MSC), a clinical stage discovery and development company announced today that it initiated a Phase 2 study in Europe with its lead product SA4503 for treatment of stroke....
Home Terms of Use Privacy Policy Contact Us